|
PD-1/PD-L1-IN-10
|
PD-1
|
2487550-41-2
|
|
EEDi-5285
|
8-(6-cyclopropylpyridin-3-yl)-N-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-1-(methylsulfonyl)imidazo[1,5-c]pyrimidin-5-amine
|
2488952-40-3
|
|
BRD4 Inhibitor-20
|
化合物 BRD4 INHIBITOR-20
|
2490311-14-1
|
|
4-Aminobenzamidine dihydrochloride
|
4-氨基苯甲脒二盐酸盐
|
2498-50-2
|
|
SR18662
|
(E)-3-(3,4-dichlorophenyl)-N-(2-(4-(methylsulfonyl)piperazin-1-yl)-2-oxoethyl)acrylamide
|
2505001-62-5
|
|
BR102910
|
(S)-N-[2-(2-氰基-4,4-二氟吡咯烷-1-基)-2-氧代乙基]-2-[(3,4-二氯苄基)噻唑-4-甲酰胺
|
2505339-54-6
|
|
K-975
|
K975
|
2563855-03-6
|
|
Cbl-b-IN-3
|
化合物 CBL-B-IN-3
|
2573775-59-2
|
|
Stafia-1
|
|
2582757-90-0
|
|
Direct Violet 1
|
直接青莲N
|
2586-60-9
|
|
NSC622608
|
3-((Furan-2-ylmethyl)imino]-N,N-dimethyl-3H-1,2,4-dithiazol-5-amine Hydrobromide
|
2593254-90-9
|
|
RBN013209
|
RBN013209
|
2597933-17-8
|
|
KIF18A-IN-2
|
化合物KIF18A-IN-2
|
2600559-20-2
|
|
ART812
|
2607138-82-7
|
2607138-82-7
|
|
Direct Red 80
|
天狼猩红
|
2610-10-8
|
|
PD-1/PD-L1-IN-9
|
化合物PD-1/PD-L1-IN-9
|
2628506-54-5
|
|
MRTX9768
|
MRTX 9768
|
2629314-68-5
|
|
ZW4864 free base
|
化合物ZW4864 FREE BASE
|
2632259-92-6
|
|
B-Raf IN 2
|
化合物B-RAF IN 2
|
2649372-20-1
|
|
CCF0058981
|
化合物CCF0058981
|
2708934-53-4
|
|
MSC-4106
|
化合物MSC-4106
|
2738542-58-8
|
|
SETDB1-TTD-IN-1
|
化合物SETDB1-TTD-IN-1
|
2755823-12-0
|
|
CSF1R-IN-3
|
化合物 CSF1R-IN-3
|
2760584-90-3
|
|
PARP-2-IN-3
|
B014
|
1215208-59-5
|
|
TPN171
|
TPN171
|
1229018-87-4
|
|
Galloylpaeoniflorin
|
没食子酰芍药苷
|
122965-41-7
|
|
Bcl-xL antagonist 2
|
BCL-XL拮抗剂2
|
1235032-75-3
|
|
Alirocumab
|
阿利库单抗
|
1245916-14-6
|
|
VU0359595
|
(1R,2R)-N-([S]-1-{4-[5-BROMO-2-OXO-2,3-DIHYDRO-1H-BENZO(D)IMIDAZOL-1-YL]PIPERIDIN-1-YL}PROPAN-2-YL)-2-PHENYLCYCLOPROPANECARBOXAMIDE;VU0359595
|
1246303-14-9
|
|
NB-360
|
2-Pyridinecarboxamide, N-[3-[(3R,6R)-5-amino-3,6-dihydro-3,6-dimethyl-6-(trifluoromethyl)-2H-1,4-oxazin-3-yl]-4-fluorophenyl]-5-cyano-3-methyl-
|
1262857-73-7
|
|
MRT-83
|
[1,1'-Biphenyl]-4-carboxaMide, N-[5-[[iMino[(3,4,5-triMethoxybenzoyl)aMino]Methyl]aMino]-2-Methylphenyl]-
|
1263131-92-5
|
|
13,21-Dihydroeurycomanone
|
Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12,14,15-pentahydroxy-, (1β,11β,12α,15β)-
|
129587-06-0
|
|
Sofosbuvir impurity G
|
索氟布韦杂质
|
1337482-15-1
|
|
AKT-IN-1
|
6-[4-(1-氨基环丁基)苯基]-5-苯基-3-吡啶甲酰胺
|
1357158-81-6
|
|
Wnt pathway activator 2
|
Wnt pathway activator 2
|
1360540-82-4
|
|
XD14
|
CS-2672
|
1370888-71-3
|
|
Pembrolizumab
|
派姆单抗
|
1374853-91-4
|
|
MAT2A inhibitor 4
|
化合物T9262
|
1391934-91-0
|
|
RIP2 Kinase Inhibitor 3
|
RIP2 Kinase Inhibitor 3
|
1398053-50-3
|
|
D-Galacturonic acid hydrate
|
甲壳素
|
1398-61-4
|
|
AZ3976
|
化合物 T23764
|
1418747-15-5
|
|
AKT-IN-6
|
INCB-047775
|
1430056-54-4
|
|
Decapeptide-12
|
SIRT-IN-1
|
1431411-60-7
|
|
2-Iodoacetamide
|
2-碘乙酰胺
|
144-48-9
|
|
L-Ascorbic acid-
|
化合物HOMO-VK-II-36
|
1479049-35-8
|
|
Flunarizine
|
NaV1.7 inhibitor-1
|
1494585-79-3
|
|
Chrysosplenol D
|
猫眼草酚
|
14965-20-9
|
|
PDE10-IN-1
|
3-Methyl-2-((1S,2S)-2-(quinolin-2-yl)cyclopropyl)-3H-iMidazo[4,5-f]quinoline
|
1516896-09-5
|
|
HBC
|
Benzeneacetonitrile, 4-cyano-α-[[4-[(2-hydroxyethyl)methylamino]phenyl]methylene]-
|
156840-13-0
|
|
BAY32-5915
|
8-羟基喹啉-2-羧酸
|
1571-30-8
|
|
(Rac)-BRD0705
|
化合物 T12664
|
1597440-03-3
|
|
Pitavastatin sodium
|
Β-香树脂醇乙酸酯
|
1616-93-9
|
|
Povorcitinib phosphate
|
POVORCITINIB磷酸盐
|
1637677-33-8
|
|
AZD0095
|
AZD0095
|
2750001-23-9
|
|
Bufarenogin
|
伪异沙蟾毒精
|
17008-65-0
|
|
Hispolon
|
HISPOLON
|
173933-40-9
|
|
AChE-IN-27
|
化合物WAY-298592
|
177028-90-9
|
|
SB-747651A dihydrochloride
|
SB-747651A二盐酸盐
|
1781882-72-1
|
|
MLT-943
|
MLT943
|
1832576-04-1
|
|
Chrysin 6-C-arabinoside 8-C-glucoside
|
白杨素 6-C-阿拉伯糖 8-C-葡萄糖苷
|
185145-33-9
|
|
WH-4-025
|
WH-4-025
|
1876463-35-2
|
|
ALDH1A3-IN-3
|
4-异丙氧基苯甲醛
|
18962-05-5
|
|
PF-04745637
|
1-(4-chlorophenyl)-N-(2-(4-hydroxy-4-(trifluoromethyl)piperidin-1-yl)-3-phenylpropyl)cyclopentanecarboxamide
|
1917294-46-2
|
|
Mitiperstat
|
AZD4831
|
1933460-19-5
|
|
IPAG
|
化合物 T22870
|
193527-91-2
|
|
Mepolizumab
|
美泊利单抗
|
196078-29-2
|
|
Myricetin 3-O-glucoside
|
杨梅素-3-O-Β-D-葡萄糖苷
|
19833-12-6
|
|
ROCK2-IN-2
|
ROCK2-IN-2
|
1995065-79-6
|
|
123C4
|
化合物123C4
|
2034159-30-1
|
|
AZD9898
|
AZD9898
|
2042347-69-1
|
|
MELK-IN-1
|
Nintedanib Impurity L
|
2095596-44-2
|
|
Lu AF27139
|
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF
|
2097117-06-9
|
|
Squarunkin A
|
化合物SQUARUNKINA
|
2101958-02-3
|
|
GSK251
|
GSK251
|
2125968-05-8
|
|
dBRD9
|
DBRD9
|
2170679-45-3
|
|
TLR7/8/9-IN-1
|
BMS-615
|
2180127-82-4
|
|
Eculizumab
|
托西珠单抗
|
219685-50-4
|
|
N-Phenylacrylamide
|
N-苯基丙烯酰胺
|
2210-24-4
|
|
(+)-Neomenthol
|
[1S-(1α,2α,5β)]-5-甲基-2-(1-甲基乙基)环己醇
|
2216-52-6
|
|
(1S,2R)-Alicapistat
|
化合物T60150
|
2221010-57-5
|
|
F-1
|
F-1
|
2244775-31-1
|
|
NPB
|
NPB
|
2247491-97-8
|
|
SGC-AAK1-1
|
AAK1 inhibitor 1
|
2247894-32-0
|
|
AAPK-25
|
AAPK-25
|
2247919-28-2
|
|
USP15-IN-1
|
化合物 USP15-IN-1
|
2260826-16-0
|
|
IRE1α kinase-IN-1
|
化合物IRE1Α KINASE-IN-1
|
2328097-41-0
|
|
ABC99
|
ABC99
|
2331255-53-7
|
|
NMS-E973
|
化合物DDO-5936
|
2355377-13-6
|
|
Lenvatinib-d
|
化合物TPX-0046
|
2359650-19-2
|
|
Pyoluteorin
|
|
2366260-33-3
|
|
DS12881479
|
化合物DS12881479
|
2373065-59-7
|
|
NF-κΒ activator 2
|
3-(2-((2-氟苯基)氨基)恶唑-5-基)苯甲酸
|
2375281-44-8
|
|
DC-TEADin02
|
化合物DC-TEADIN02
|
2380228-45-3
|
|
LOX-IN-3 dihydrochloride
|
PS-5505
|
2409964-23-2
|
|
MYF-01-37
|
MYF-01-37
|
2416417-65-5
|
|
PROTAC BRAF-V600E degrader-1
|
化合物2417296-84-3
|
2417296-84-3
|
|
VT104
|
|
2417718-25-1
|
|
CCT128930 hydrochloride
|
4-(4-Chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine hydrochloride
|
2453324-32-6
|
|
PCSK9-IN-12
|
化合物AZD0780
|
2455427-91-3
|
|
USP8-IN-1
|
USP8 inhibitor
|
2477650-96-5
|